ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2762

Atrophy of Hippocampal Region in Chronic Progressive Neuro-Behçet’s Disease

Hirotoshi Kikuchi1, Kurumi Asako1, Maki Takayama1, Yoshitaka Kimura1, Akiko Okamoto1, Toshihiro Nanki1,2, Hajime Kono1 and Shunsei Hirohata3, 1Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan, 2Department of Clinical Research Medicine, Teikyo University, Tokyo, Japan, 3Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, MRI and neurologic involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Central nervous system involvement in Behçet’s disease, usually called neuro-Behçet’s disease (NB), can be classified into acute NB (ANB) and chronic progressive NB (CPNB) based upon the differences in clinical courses and responses to corticosteroid treatment. Previous studies demonstrated that brainstem atrophy was significantly more frequently observed in CPNB than in ANB or non-NB. Noteworthy, in addition to truncal ataxia, neurobehavioral changes are frequently observed in CPNB, which cannot be accounted for by brainstem atrophy. In the present study we examined the volumes of hippocampus in order to determine the responsible lesions for neurobehavioral changes in CPNB.

Methods: A total of 26 patients were studied, including 13 patients with CPNB (11 males and 2 females, age 51.2 ± 12.1 [mean ± SD]) and 13 non-NBD (10 males and 3 females, age 54.4 ± 11.4). All the patients satisfied the international classification criteria for Behçet’s disease. CPNB was defined as intractable, slowly progressive neurobehavioral changes and/or ataxia accompanied by the persistent elevation of cerebrospinal fluid of IL-6 more than 20 pg/mL on two different occasions at intervals of at least 2 weeks (3). The sagittal sections of T1-weighted images on brain MRI were obtained from each patient. Severity of gray matter loss in the hippocampal region and whole brain were investigated by the software for Voxel-Based Specific Regional Analysis System for Alzheimer’s Disease (VSRAD) (Eisai Co., Ltd), calculating the indicators of the degrees of hippocampal region atrophy (HAI) and those of whole-brain atrophy (WBAI). The areas of midbrain tegmentum and pons were measured on mid-sagittal sections of T1-weightened images of brain MRI using image analysis software Image J (NIH, U.S.).

Results: The VSRAD analysis showed that HAI was significantly increased in CPNB (1.46 ± 0.70 [mean ± SD]) compared with in non-NB (0.77 ± 0.40) (p=0.0016) (Fig. 1). Although less markedly, WBAI was significantly higher in CPNB (10.6 ± 5.0) than in non-NB (6.9 ± 1.7) (p=0.0240). Neither HAI nor WBAI was correlated with age. Whereas all the patients with CPNB showed brainstem atrophy, there was no significant correlation between HAI and the rate of brainstem atrophy (Fig. 2).

Conclusion: These results indicate that hippocampus, in addition to brainstem, is a commonly affected lesion in CPNB, accounting for progressive neurobehavioral changes. The lack of correlation between brainstem atrophy and hippocampal atrophy suggest that there might be some predisposing factors determining the preference of affected lesions in CPNB.


Disclosure:

H. Kikuchi,
None;

K. Asako,
None;

M. Takayama,
None;

Y. Kimura,
None;

A. Okamoto,
None;

T. Nanki,
None;

H. Kono,
None;

S. Hirohata,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/atrophy-of-hippocampal-region-in-chronic-progressive-neuro-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology